Table 2.
Experimental induction of type-2 diabetes by streptozotocin (STZ) injection.
| S. no. | Groups | Blood sugar concentration (mg/dL) in overnight fasting rats before the injection of Streptozotocin (STZ) | Blood sugar concentration (mg/dL) after the injection of Streptozotocin (STZ) |
|---|---|---|---|
| 1 | Control (normal rats) |
i. 102 ii. 92 iii. 87 iv. 108 |
– |
| 2 | Diabetic without ulcer (untreated rats) |
i. 98 ii. 90 iii. 89 iv. 99 |
i’. 368 ii’. 239 iii’. 366 iv’. 261 |
| 3 |
Pseudomonas aeruginosa Diabetic with ulcer (untreated rats) |
i. 110 ii. 102 iii. 94 iv. 87 |
i’. 325 ii’. 338 iii’. 302 iv’. 319 |
| 4 |
Pseudomonas aeruginosa Diabetic with ulcer (TBO–chit–Au–AgNPs treated rats) |
i. 95 ii. 130 iii. 94 iv. 102 |
i’. 380 ii’. 397 iii’. 394 iv’. 382 |
| 5 |
Pseudomonas aeruginosa Diabetic with ulcer (TBO–chit–Au–AgNPs + light treated rats) |
i. 108 ii. 100 iii. 80 iv. 98 |
i’. 376 ii’. 265 iii’. 277 iv’. 264 |
| 6 |
Staphylococcus aureus Diabetic with ulcer (untreated rats) |
i. 138 ii. 112 iii. 98 iv. 104 |
i’. 309 ii’. 386 iii’. 287 iv’. 312 |
| 7 |
Staphylococcus aureus Diabetic with ulcer (TBO–chit–Au–AgNPs treated rats) |
i. 139 ii. 87 iii. 94 iv. 93 |
i’. 299 ii’. 310 iii’. 264 iv’. 317 |
| 8 |
Staphylococcus aureus Diabetic with ulcer (TBO–chit–Au–AgNPs + light treated rats) |
i. 130 ii. 123 iii. 117 iv. 103 |
i’. 385 ii’. 305 iii’. 377 iv’. 338 |
| 9 |
Polymicrobial (Staphylococcus aureus + Pseudomonas aeruginosa) Diabetic with ulcer (untreated rats) |
i. 104 ii. 110 iii. 96 iv. 117 |
i’. 291 ii’. 271 iii’. 359 iv’. 331 |
| 10 |
Polymicrobial (Staphylococcus aureus + Pseudomonas aeruginosa) Diabetic with ulcer (TBO–chit–Au–AgNPs treated rats) |
i. 109 ii. 106 iii. 103 iv. 122 |
i’. 362 ii’. 358 iii’. 376 iv’. 321 |
| 11 |
Polymicrobial (Staphylococcus aureus + Pseudomonas aeruginosa) Diabetic with ulcer (TBO–chit–Au–AgNPs + light treated rats) |
i. 106 ii. 114 iii. 73 iv. 111 |
i’. 319 ii’. 375 iii’. 332 iv’. 345 |